Clinical Trials on Infection, Viral, Enterovirus in Hong Kong

Total 1121 results

Immuno Cure 3 Limited
The University of Hong Kong

Active, not recruiting

Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)

COVID-19

Hong Kong
Hong Kong Baptist University

Recruiting

Electro-acupuncture for Long Covid Neuropsychiatric Symptoms

Long Covid19 | Neuropsychiatric Symptoms | Electro-acupuncture

Hong Kong
Hong Kong Baptist University
Hospital Authority, Hong Kong

Recruiting

The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients (HKCOVID19Res)

Covid-19

Hong Kong
Hong Kong Baptist University
University of California, San Diego; The University of Hong Kong; Yale University and other collaborators

Recruiting

Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients (Covid19Reh)

Coronavirus Disease (COVID-19)

Hong Kong
Hong Kong Baptist University
Tseung Kwan O Hospital, Hong Kong; Haven of Hope - The Chinese University of...

Not yet recruiting

Acupuncture for Olfactory Dysfunction in Infected COVID-19 Patients

Covid19 | Olfactory Dysfunction

Hong Kong
Humanity and Health Research Centre
Beijing 302 Hospital; Nanfang Hospital of Southern Medical University

Completed

DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO) (DASCO)

Chronic Hepatitis C Infection | Hepatitis B Reactivation | HBV Coinfection

China
Chinese University of Hong Kong

Completed

Seroepidemiology of Viral Hepatitis in Hong Kong

Viral Hepatitis

China
The University of Hong Kong

Completed

Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong

Hepatitis B Infection

China
The University of Hong Kong
Hospital Authority, Hong Kong

Completed

Quality of Life and Health Utility of Patients With CHB Infections

Chronic Hepatitis B Infection

Hong Kong
The University of Hong Kong

Completed

ID HBV Vaccination With Imiquimod in OBI

Hepatitis B

Hong Kong
The University of Hong Kong
Research Grant Council

Recruiting

Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B

Cirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 Inhibitors

Hong Kong
The University of Hong Kong

Recruiting

Emergency PWAS in Respiratory Infectious Disease

Pneumonia | Sepsis | Bacterial Infections | Viral Infections | Fungal Infections | Mycobacterium Infection | Mixed Infection | Infection of Uncertain Aetiology

China
The University of Hong Kong

Completed

Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study

Exposure to Hepatitis B Virus

Hong Kong
Humanity & Health Medical Group Limited

Withdrawn

Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection

HCV Infection

Hong Kong
The University of Hong Kong

Recruiting

Detecting Occult HBV Infection in Liver Donors Positive for Antibody to Hepatitis B Core Antigen (Anti-HBc) (OBI)

Liver Transplant; Complications | Occult Hepatitis B

Hong Kong
The University of Hong Kong

Recruiting

Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR) (R-COVID-CMR)

Covid19 | Viral Respiratory Infection

Hong Kong
The University of Hong Kong

Completed

Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) Exposure

Exposure to Hepatitis B Virus

Hong Kong
The University of Hong Kong

Completed

Off Treatment Durability in Chronic Hepatitis B With Good Immune Control

Chronic Hepatitis B

Hong Kong
The University of Hong Kong
Gilead Sciences

Completed

Tenofovir in Asian Chronic Hepatitis B Patients

Chronic Hepatitis B

Hong Kong
Chinese University of Hong Kong

Completed

Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B

Chronic Hepatitis B

Hong Kong
F-star Therapeutics, Inc.
PRA Health Sciences

Terminated

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus

Hepatitis B | Hepatitis B, Chronic | HBV

Hong Kong
Chinese University of Hong Kong
University of Malaya

Terminated

Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients

Immunosuppression | Occult Hepatitis B | Biological Substance; Adverse Effect

Hong Kong
Humanity and Health Research Centre

Recruiting

Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDF (SWITAF)

Chronic Hepatitis B

Hong Kong
Hospital Authority, Hong Kong

Completed

A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers

Neoplasms | Hepatitis B

China
Suzhou Ribo Life Science Co. Ltd.

Completed

A Single and Repeated Dose Escalation of RBD1016 in Subjects With Chronic Hepatitis B Virus (HBV) Infection

Chronic Hepatitis b

China
Chinese University of Hong Kong

Terminated

Novel SARS-CoV-2 Point-of-care Testing

SARS-CoV2 Infection

Hong Kong
Novartis Pharmaceuticals

Completed

Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB

Hepatitis B Virus

China
The Hong Kong Polytechnic University
Food and Health Bureau, Hong Kong

Recruiting

Community-Based Health Education Programs for the Early Detection of, and Vaccination Against, COVID-19 and the Adoption of Self-Protective Measures of Hong Kong Residents

COVID-19

Hong Kong
Hospital Authority, Hong Kong
Vigconic (International) Ltd.

Completed

A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis

Liver Cirrhosis | Hepatitis B | Hepatitis C

China
The University of Hong Kong

Recruiting

Epidural Platelet Rich Plasma Injection for Herpes Zoster

Acute Herpes Zoster Neuropathy

Hong Kong
The University of Hong Kong

Completed

Intra-dermal With Topical Imiquimod Pretreatment Versus Intra-muscular Hepatitis B Vaccination in IBD Patients

Hepatitis B | Inflammatory Bowel Diseases

China
The University of Hong Kong
Novartis Pharmaceuticals

Completed

Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)

Chronic Hepatitis B

China
The University of Hong Kong

Completed

Intradermal Influenza Vaccine in the Young

Influenza Viral Infections

China
GlaxoSmithKline

Completed

Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)

Chronic Hepatitis B

Hong Kong
The University of Hong Kong

Not yet recruiting

Changing Susceptible Body Constitution for COVID-19 Prevention by Chinese Medicine in Hong Kong Residents

COVID19 | Herbal Medicine

Hong Kong
The University of Hong Kong

Completed

Quadruple Versus Sequential Therapy for Helicobacter Pylori Eradication

Helicobacter Pylori Infection

Hong Kong
The Hong Kong Polytechnic University

Recruiting

A Blended Gaming COVID-19 Training System (BGCTS) With WHO Guidelines for Staff in Residential Care Homes (BGCTS)

COVID-19 | Infection Control

Hong Kong
The Hong Kong Polytechnic University

Recruiting

Integrated Mindfulness-based Health Qigong Intervention for COVID-19 Survivors and Caregivers

COVID-19 Infection

Hong Kong
The University of Hong Kong

Completed

Renoprotective Effects of Telbivudine in Chronic Hepatitis B

Chronic Kidney Diseases | Hepatitis B, Chronic

Hong Kong
Arrowhead Pharmaceuticals
ICON Clinical Research

Terminated

A Multicenter Study to Determine the Depth and Duration of Hepatitis B Surface Antigen (HBsAg) Reduction After Single or Multiple Doses of ARC-520, in Combination With Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection

Hepatitis B, Chronic

Hong Kong
Hong Kong University of Science and Technology
Chinese University of Hong Kong; Prince of Wales Hospital, Shatin, Hong Kong

Recruiting

Large-scale COVID-19 Population Screening

Covid19

Hong Kong
The University of Hong Kong

Completed

Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori Eradication

Helicobacter Pylori Infection

Hong Kong
Chinese University of Hong Kong

Recruiting

Mycoplasma Genitalium Infection and Associated Antimicrobial Resistance Among HIV-infected Male in Hong Kong

STI | Mycoplasma Genitalium Infection

Hong Kong
Chinese University of Hong Kong
GlaxoSmithKline; Hoffmann-La Roche

Completed

Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients

Chronic Hepatitis B

China
Chinese University of Hong Kong
GlaxoSmithKline

Completed

Trial of Lamivudine Treatment in HBeAg Negative Chronic Hepatitis B Patients (in Asia)

Chronic Hepatitis B

China
Humanity and Health Research Centre

Recruiting

Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease

Chronic Hepatitis B | Nonalcoholic Fatty Liver Disease

China
Chinese University of Hong Kong
Hoffmann-La Roche

Completed

Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral Treatment

Chronic Hepatitis B

China
Chinese University of Hong Kong

Recruiting

Respiratory Virus Metagenomics After COVID-19

COVID-19 Respiratory Infection

China
Humanity & Health Medical Group Limited

Recruiting

Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)

Chronic Hepatitis B

Hong Kong
Humanity and Health Research Centre
University of Maryland; Emory University; Beijing 302 Hospital

Withdrawn

Triple Combination DAAs for Treating HCV GT1b Subjects

Chronic Hepatitis C Infection

Hong Kong

Clinical Trials on Infection, Viral, Enterovirus in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations